Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study

Affiliations

¹ Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Electronic address: Ellen.Kim@uphs.upenn.edu.
² Department of Dermatology, Columbia University, New York, New York.
³ Department of Dermatology, Northwestern University, Chicago, Illinois.
⁴ Division of Dermatology, City of Hope, Duarte, California.
⁵ Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
⁶ Division of Dermatology, Washington University in St. Louis School of Medicine, Saint Louis, Missouri.
⁷ Helsinn Therapeutics (US), Inc, Iselin, NJ.
⁸ ICON Commercialization & Outcomes, Dublin, Ireland.

Observational Study

Ellen J Kim et al. J Am Acad Dermatol. 2020 Sep.

. 2020 Sep;83(3):928-930.

doi: 10.1016/j.jaad.2019.12.070. Epub 2020 Feb 20.

¹ Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Electronic address: Ellen.Kim@uphs.upenn.edu.
² Department of Dermatology, Columbia University, New York, New York.
³ Department of Dermatology, Northwestern University, Chicago, Illinois.
⁴ Division of Dermatology, City of Hope, Duarte, California.
⁵ Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
⁶ Division of Dermatology, Washington University in St. Louis School of Medicine, Saint Louis, Missouri.
⁷ Helsinn Therapeutics (US), Inc, Iselin, NJ.
⁸ ICON Commercialization & Outcomes, Dublin, Ireland.

No abstract available

Publication types